Puma Biotechnology Announces Amendment to Neratinib Licensing Agreement[...]
Puma Biotechnology Announces Positive Top Line Results from Phase III[...]
Puma Biotechnology Reports Second Quarter 2014 Financial Results
05/07/2024 | Press release | Distributed by Public on 05/07/2024 04:30
Please select the service you want to use:
Smartlinks | Emerald Holding Inc. | Company News | Securities Issuers | Event Management Companies | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact